Cargando…
Application of synthetic biology in bladder cancer
Bladder cancer (BC) is the most common malignant tumor of the genitourinary system. The age of individuals diagnosed with BC tends to decrease in recent years. A variety of standard therapeutic options are available for the clinical management of BC, but limitations exist. It is difficult to surgica...
Autores principales: | Ding, Mengting, Lin, Jiaxing, Qin, Caipeng, Wei, Ping, Tian, Jiahe, Lin, Tianxin, Xu, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771244/ https://www.ncbi.nlm.nih.gov/pubmed/36209735 http://dx.doi.org/10.1097/CM9.0000000000002344 |
Ejemplares similares
-
Gemcitabine-Resistant Biomarkers in Bladder Cancer are Associated with Tumor-Immune Microenvironment
por: Song, Yuxuan, et al.
Publicado: (2022) -
Emerging strategies for the improvement of chemotherapy in bladder cancer: Current knowledge and future perspectives
por: Liu, Sen, et al.
Publicado: (2021) -
Involvement of cancer-derived IgG in the proliferation, migration and invasion of bladder cancer cells
por: Sheng, Zhengzuo, et al.
Publicado: (2016) -
Intratumoral fibrosis and patterns of immune infiltration in clear cell renal cell carcinoma
por: Han, Songchen, et al.
Publicado: (2022) -
Effect of regional versus general anesthesia on recurrence of non-muscle invasive bladder cancer: a systematic review and meta-analysis of eight retrospective cohort studies
por: Wang, Yulong, et al.
Publicado: (2023)